What is Novelion Therapeutics Inventory-to-Revenue?
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Novelion Therapeutics's Average Total Inventories for the quarter that ended in Mar. 2019 was €11.5 Mil. Novelion Therapeutics's Revenue for the
three
months ended in Mar. 2019 was €28.5 Mil.
Novelion Therapeutics's Inventory-to-Revenue for the quarter that ended in Mar. 2019 was 0.41.
Novelion Therapeutics's Inventory-to-Revenue for the quarter that ended in Mar. 2019
increased
from Dec. 2018 (0.39) to Dec. 2018 (0.41)
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Novelion Therapeutics's Days Inventory for the
three
months ended in Mar. 2019 was 78.14.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Novelion Therapeutics's Inventory Turnover for the quarter that ended in Mar. 2019 was 1.17.
Novelion Therapeutics Inventory-to-Revenue Historical Data
The historical data trend for Novelion Therapeutics's Inventory-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Novelion Therapeutics's Inventory-to-Revenue
For the Biotechnology subindustry, Novelion Therapeutics's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Novelion Therapeutics's Inventory-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Novelion Therapeutics's Inventory-to-Revenue distribution charts can be found below:
* The bar in red indicates where Novelion Therapeutics's Inventory-to-Revenue falls into.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Novelion Therapeutics's Inventory-to-Revenue for the fiscal year that ended in Dec. 2018 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:
1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.
More Related Terms:
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Novelion Therapeutics's Days Inventory for the
three
months ended in Mar. 2019 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Novelion Therapeutics Inventory-to-Revenue Related Terms
Thank you for viewing the detailed overview of Novelion Therapeutics's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Novelion Therapeutics (STU:QLTA) Business Description
Headquartered in Vancouver, Canada, QLT is a biotechnology company that researches and develops products used to treat conditions of the eye. After a recent board change, QLT divested its only marketed product, a laser treatment called Visudyne for the treatment of wet age-related macular degeneration and subfoveal choroidal neovascularization. QLT also earns royalty payments on other certain previously divested products. Following recent pipeline changes, the company currently has one product in development for two rare eye conditions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
STU:QLTA has been successfully added to your 